Abstract
Exposure to ambient air pollution contributes substantially to the global burden of disease, and in 2015, ambient exposure to PM2.5 (fine particles with a mass median aerodynamic diameter of less than 2.5 μm) was the fifth-ranking risk factor of mortality globally. We analyzed data from the US zip code tabulation areas (N=32047) for 2000-2016 and found strong evidence of inequalities in exposure to PM2.5 among both racial/ethnic and income groups. Most alarming, we found that these inequalities have been increasing over time. From 2010 to 2016 inequalities in the exposure to PM2.5 levels above 8 μg/m3 across racial/ethnic, and income groups increased by factors of 1.6 and 4.0 respectively. As shown in our powerful map visualizations, these results indicate that air pollution regulations must not only decrease PM2.5 concentration levels nationwide but also prioritize reducing environmental injustice across the US.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported financially by grants from the Health Effects Institute (4953- RFA14-3/16-4), National Institute of Health (DP2MD012722), National Institute of Health and Yale University (R01MD012769), National Institute of Health and National Institute of Environmental Health Sciences (R01 ES028033) and the Environmental Protection Agency (83587201-0).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be made accessible upon manuscript acceptance in a peer reviewed journal through the publishing journal.
